Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Net Margin (2016 - 2026)

Biomerica's Net Margin history spans 17 years, with the latest figure at 132.93% for Q1 2026.

  • On a quarterly basis, Net Margin fell 2900.0% to 132.93% in Q1 2026 year-over-year; TTM through Feb 2026 was 96.49%, a 1255.0% decrease, with the full-year FY2025 number at 93.64%, up 1521.0% from a year prior.
  • Net Margin hit 132.93% in Q1 2026 for Biomerica, down from 109.09% in the prior quarter.
  • Over the last five years, Net Margin for BMRA hit a ceiling of 0.14% in Q3 2025 and a floor of 206.14% in Q2 2025.
  • Historically, Net Margin has averaged 102.03% across 5 years, with a median of 109.09% in 2025.
  • Biggest five-year swings in Net Margin: surged 12918bps in 2022 and later crashed -14716bps in 2023.
  • Tracing BMRA's Net Margin over 5 years: stood at 109.72% in 2022, then increased by 12bps to 96.17% in 2023, then soared by 40bps to 58.07% in 2024, then tumbled by -88bps to 109.09% in 2025, then dropped by -22bps to 132.93% in 2026.
  • Business Quant data shows Net Margin for BMRA at 132.93% in Q1 2026, 109.09% in Q4 2025, and 0.14% in Q3 2025.